Kiniksa Pharmaceuticals Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$285,970	$243,600	$214,266	$202,127
Gross Profit	152,383	131,959	117,893	111,031
EBITDA	59,547	27,666	33,149	23,736
EBIT	59,057	27,194	32,681	23,269
Net Income	47,345	25,432	22,592	14,199
Net Change In Cash	285,970	243,600	214,266	202,127
Free Cash Flow	47,103	46,796	50,038	53,260
Cash	81,660	175,677	189,952	165,596
Basic Shares	84,920	83,398	82,409	78,979

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$677,564	$423,239	$270,259	$220,180
Gross Profit	370,150	362,329	213,735	197,285
EBITDA	90,422	-34,457	-14,311	13,428
EBIT	88,868	-36,152	-16,652	11,026
Net Income	59,005	-43,193	14,084	183,363
Net Change In Cash	677,564	423,239	270,259	220,180
Cost of Revenue				245
Free Cash Flow	25,412	25,412	13,171	5,702
Cash	165,596	183,581	107,954	122,715
Basic Shares	78,979	71,424	71,922	70,421